- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
News 95 results
In the News · Source: Law360
April 29, 2021
Tom Spulak discusses the FBI's investigation into Rudy Giuliani
In the News · Source: The Deal
In the News · Source: Bloomberg Law
April 20, 2021
Tom Spulak and Steve Cave discuss the impact of President Biden’s infrastructure plan on government and private contractors
Press Release
March 29, 2021
FDA Acting Policy Director for Office of Therapeutic Biologics and Biosimilars Joins King & Spalding
In the News · Source: Law.com
In the News · Source: Politico
In the News · Source: Bloomberg Government
February 19, 2021
Bloomberg Government highlights Tom Spulak and George Crawford's webinar with Pete Robinson, former Senate Senior Assistant Parliamentarian
In the News · Source: Global Legal Chronicle
Press Release
January 7, 2021
King & Spalding’s FDA and Life Sciences Team Adds Partner in Washington
Cases & Deals
December 31, 2020
King & Spalding Advises on Landmark Medicare Reform Bills BENES Act and PAID Act, Both Passed By Congress
In the News · Source: The Baltimore Sun
December 28, 2020
The Baltimore Sun highlights former Governor of Maryland Robert Ehrlich in an extensive profile
In the News · Source: Pink Sheet
December 7, 2020
Allison Kassir comments on Xavier Becerra’s nomination by President-elect Biden to head the Department of Health and Human Services